
Photo: investor.agenusbio.com
Apr 18, 2025, 01:17
Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
Agenus shared a post on LinkedIn:
“Stay tuned for AACR25, where Dr. Anthony El-khoueiry will present data from our Phase 1 trial evaluating botensilimab/balstilimab in treatment-refractory hepatocellular carcinoma (HCC).
More posts featuring Agenus.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 27, 2025, 20:24
Apr 27, 2025, 20:04
Apr 27, 2025, 19:48
Apr 27, 2025, 18:59
Apr 27, 2025, 18:55